INOVIO to Report Fourth Quarter and Year-End 2021 Financial Results on March 1, 2022PRNewsWire • 02/15/22
Down 21.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Inovio (INO)Zacks Investment Research • 01/11/22
Is A Rise Imminent For Inovio Pharmaceuticals Stock After A Large 17% Fall In A MonthForbes • 12/17/21
INOVIO Highlights Key Updates on Phase 3 Program for VGX-3100, its DNA-based Immunotherapy for the Treatment of Cervical HSIL Caused by HPV-16 and/or HPV-18PRNewsWire • 12/14/21
INOVIO Announces Strategy to Address Omicron (B.1.1.529) and Future SARS-CoV-2 VariantsPRNewsWire • 11/30/21
Inovio Pharmaceuticals: Forget The COVID Pump, And Keep Your Eye On The Oncology SideSeeking Alpha • 11/18/21
INOVIO Collaborates with GuardRX and Geneva University Hospitals for Heterologous Booster Clinical Trial of its Ebola DNA Vaccine Candidate, INO-4201PRNewsWire • 11/16/21
INOVIO to Give Eight Presentations at the 34th International Papillomavirus ConferencePRNewsWire • 11/15/21
Inovio Pharmaceuticals, Inc. (INO) CEO Joseph Kim on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/10/21